BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3132586)

  • 1. Amino acid sequence homology between the enzymic domains of diphtheria toxin and Pseudomonas aeruginosa exotoxin A.
    Carroll SF; Collier RJ
    Mol Microbiol; 1988 Mar; 2(2):293-6. PubMed ID: 3132586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active site of Pseudomonas aeruginosa exotoxin A. Glutamic acid 553 is photolabeled by NAD and shows functional homology with glutamic acid 148 of diphtheria toxin.
    Carroll SF; Collier RJ
    J Biol Chem; 1987 Jun; 262(18):8707-11. PubMed ID: 2885323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
    Wilson BA; Collier RJ
    Curr Top Microbiol Immunol; 1992; 175():27-41. PubMed ID: 1628498
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic activity of a recombinant chimaeric protein between Pseudomonas aeruginosa exotoxin A and Corynebacterium diphtheriae diphtheria toxin.
    Guidi-Rontani C
    Mol Microbiol; 1992 May; 6(10):1281-7. PubMed ID: 1640830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological cross-reactivity in the absence of DNA homology between Pseudomonas toxin A and diphtheria toxin.
    Sadoff JC; Buck GA; Iglewski BH; Bjorn MJ; Groman NB
    Infect Immun; 1982 Jul; 37(1):250-4. PubMed ID: 6179878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the enzymatic active site of Pseudomonas aeruginosa exotoxin A.
    Brandhuber BJ; Allured VS; Falbel TG; McKay DB
    Proteins; 1988; 3(3):146-54. PubMed ID: 3151219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of synthetic peptides and site-specific antibodies to localize a diphtheria toxin sequence associated with ADP-ribosyltransferase activity.
    Olson JC
    J Bacteriol; 1993 Feb; 175(3):898-901. PubMed ID: 8423159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the structure-function relationship of Pseudomonas aeruginosa exotoxin A.
    Wick MJ; Hamood AN; Iglewski BH
    Mol Microbiol; 1990 Apr; 4(4):527-35. PubMed ID: 2112672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
    Gallant CV; Raivio TL; Olson JC; Woods DE; Storey DG
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. His-426 of the Pseudomonas aeruginosa exotoxin A is required for ADP-ribosylation of elongation factor II.
    Wozniak DJ; Hsu LY; Galloway DR
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8880-4. PubMed ID: 3143111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer modelling of the NAD binding site of ADP-ribosylating toxins: active-site structure and mechanism of NAD binding.
    Domenighini M; Montecucco C; Ripka WC; Rappuoli R
    Mol Microbiol; 1991 Jan; 5(1):23-31. PubMed ID: 1901617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity.
    Wedekind JE; Trame CB; Dorywalska M; Koehl P; Raschke TM; McKee M; FitzGerald D; Collier RJ; McKay DB
    J Mol Biol; 2001 Dec; 314(4):823-37. PubMed ID: 11734000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active site mutations of Pseudomonas aeruginosa exotoxin A. Analysis of the His440 residue.
    Han XY; Galloway DR
    J Biol Chem; 1995 Jan; 270(2):679-84. PubMed ID: 7822295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin.
    Li M; Dyda F; Benhar I; Pastan I; Davies DR
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9308-12. PubMed ID: 7568123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa exotoxin A.
    Chaudry GJ; Holmans PL; Clowes RC; Draper RK
    Targeted Diagn Ther; 1992; 7():405-23. PubMed ID: 1633302
    [No Abstract]   [Full Text] [Related]  

  • 16. Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa.
    Gray GL; Smith DH; Baldridge JS; Harkins RN; Vasil ML; Chen EY; Heyneker HL
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2645-9. PubMed ID: 6201861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dipeptide insertion in domain I of exotoxin A that impairs receptor binding.
    Chaudry GJ; Wilson RB; Draper RK; Clowes RC
    J Biol Chem; 1989 Sep; 264(25):15151-6. PubMed ID: 2570071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of exotoxin A-related protein of Pseudomonas aeruginosa lacking residues 225-412.
    Guidi-Rontani C
    FEMS Microbiol Lett; 1991 May; 64(1):103-9. PubMed ID: 1906825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa exotoxin A: effects of mutating tyrosine-470 and tyrosine-481 to phenylalanine.
    Lukac M; Collier RJ
    Biochemistry; 1988 Oct; 27(20):7629-32. PubMed ID: 2849995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dominant-negative approach that prevents diphthamide formation confers resistance to Pseudomonas exotoxin A and diphtheria toxin.
    Roy V; Ghani K; Caruso M
    PLoS One; 2010 Dec; 5(12):e15753. PubMed ID: 21203470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.